Ranjith Kumavath

Central University of KeralaIndia

Dr. Ranjith Kumavath, MSc, PhD, FASB, was born in 1979 to a lovely Rajput Indian couple and grew up in south India. He received his PhD degree from the University of Hyderabad. Before joining CUK in 2011, he worked as a postdoctoral research fellow at the University of Hyderabad, Singapore and the USA. He has been awarded as Young Scientist by DST, Govt. of India; BioAsia Young Scientist by govt. of Andhra Pradesh; Fellow of the Society of Applied Biotechnology by SAB; Fellow of Young Investigator by India Biosciences and Mahatma Gandhi Gold Medal Award 2014; and APJ Abdul Kalam Award by GEPRA, India. Currently, he is operating four major research projects funded by UGC-BSR, SERB-DST and SERB, Govt. of India. He has published 2 books, 6 chapters and 23 research publications in leading international journals, and he has made 18 national and 16 international presentations. He has contributed in discovery of four novel enzymes to IUBMB. He has collaborations with UoH, IIOAB, Cancer Science Institute of Singapore and San Diego State University, USA. His main research interest areas are cancer genomics, microbial genetics and metagenomics, human infective diseases and computational drug designing. His research group is being dedicated towards developing anti-cancer agents from microbial recourses for target-based drug discovery.

2books edited

3chapters authored

Latest work with IntechOpen by Ranjith Kumavath

This book focuses on metagenomics for gut microbiomes. The host is deprived of various benefits derived from the numerous gut microbes for food metabolism and health. However, polysaccharides such as cellulose, xylans, resistant starch, and inulin that are found in vegetables in our diet are digested by certain species that colonize the intestines. In contrast, metagenomic studies that reiterate microbiome intrinsic factors from particular communities and lifestyles and are extremely important for bacterial communities traveling over a long distance have entered a new era. Predominantly to understand the behavior of organisms and their action in a host, next-generation sequencing will provide a new insight into analyzing the livestock industry, agriculture, and human health risks and will consider for future development novel therapies for various diseases through identification of advanced tools. Hence, the book will give more precise information on the role of gut microbiomes in the host.

Go to the book